Bayview Acquisition Corp Announces Favorable Nasdaq Listing Decision
Bayview Acquisition Receives Permission To Continue Listing On Nasdaq, But Most Close Business Combination With Oabay And Demonstrate Listing Rules Compliance By June 19
Bayer (0P6S) Receives a Hold from J.P. Morgan
Bayer enters licensing agreement with Dewpoint Therapeutics
J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)
Goldman Sachs Reaffirms Their Hold Rating on Bayer (0P6S)
Deutsche Bank Keeps Their Hold Rating on Bayer (0P6S)
Bayer (0P6S) Gets a Hold from Kepler Capital
Bayer (0P6S) Receives a Hold from Jefferies
Bayer (0P6S) Gets a Hold from J.P. Morgan
J.P. Morgan Remains a Hold on Bayer (0P6S)
UBS Reaffirms Their Hold Rating on Bayer (0P6S)
DZ BANK AG Sticks to Their Buy Rating for Bayer (0P6S)
Kepler Capital Keeps Their Hold Rating on Bayer (0P6S)
UBS Remains a Hold on Bayer (0P6S)
Deutsche Bank Sticks to Its Hold Rating for Bayer (0P6S)
Jefferies Sticks to Its Hold Rating for Bayer (0P6S)
Goldman Sachs Sticks to Its Hold Rating for Bayer (0P6S)
UBS Keeps Their Hold Rating on Bayer (0P6S)
J.P. Morgan Sticks to Its Hold Rating for Bayer (0P6S)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.